Gilead Sciences (GILD)

66.58 +0.72 (1.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/24/19)
- M&A (12/31/17 *Est)

Latest Headlines

Gilead Sciences (GILD) October weekly option implied volatility elevated on more calls than puts October 23, 2019 10:13 AM - StreetInsider UPDATE: BofA/Merrill Lynch Reinstates Gilead Sciences (GILD) at Neutral October 16, 2019 4:32 PM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Oct 15 October 15, 2019 9:04 AM - SEC Filing Gilead Sciences (GILD) Appoints Andrew Dickinson as CFO October 15, 2019 8:30 AM - StreetInsider Gilead Sciences Appoints Andrew Dickinson as Chief Financial Officer October 15, 2019 8:30 AM - BizWire Bernstein Reinstates Gilead Sciences (GILD) at Outperform October 14, 2019 7:03 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $75 at Morgan Stanley October 11, 2019 8:45 AM - StreetInsider Gilead Sciences (GILD), Galapagos NV (GLPG) Report Efficacy & Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis October 11, 2019 6:04 AM - StreetInsider Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis October 10, 2019 6:00 PM - BizWire Gilead Sciences to Release Third Quarter 2019 Financial Results on Thursday, October 24, 2019 October 10, 2019 4:05 PM - BizWire Gilead Sciences (GILD) October weekly calls active, shares up 1% October 10, 2019 10:45 AM - StreetInsider Gilead Sciences (GILD) Gains on Chatter October 10, 2019 9:40 AM - StreetInsider Gilead Sciences (GILD) Submits NDA for Filgotinib for Treatment of Adults With Rheumatoid Arthritis in Japan October 8, 2019 6:21 AM - StreetInsider Gilead Sciences Submits New Drug Application for Filgotinib for the Treatment of Adults With Rheumatoid Arthritis in Japan October 8, 2019 2:00 AM - BizWire Gilead Sciences (GILD) Names Merdad Parsey, MD, PhD Chief Medical Officer October 7, 2019 8:33 AM - StreetInsider Gilead Sciences Appoints Merdad Parsey, MD, PhD as Chief Medical Officer October 7, 2019 8:30 AM - BizWire Gilead Sciences (GILD) Presents New Data From the Company’s HIV Clinical Development Program and Latest Findings on the Impact of HIV PrEP at IDWeek October 4, 2019 8:39 AM - StreetInsider Gilead Presents New Data From the Company’s HIV Clinical Development Program and Latest Findings on the Impact of HIV Pre-exposure Prophylaxis (PrEP) at IDWeek 2019 October 4, 2019 8:30 AM - BizWire Form 4 GILEAD SCIENCES INC For: Oct 01 Filed by: Lofton Kevin E October 3, 2019 9:04 PM - SEC Filing Gilead Sciences (GILD) Announces U.S. FDA Approves Descovy for HIV Pre-Exposure Prophylaxis October 3, 2019 2:49 PM - StreetInsider U.S. Food and Drug Administration Approves Descovy® for HIV Pre-Exposure Prophylaxis (PrEP) October 3, 2019 2:49 PM - BizWire Form 4 GILEAD SCIENCES INC For: Sep 27 Filed by: Whitley Richard James September 30, 2019 8:05 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: Sep 27 Filed by: Lofton Kevin E September 30, 2019 8:01 PM - SEC Filing Companies with NDRs 09/27 September 27, 2019 7:15 AM - StreetInsider Companies with NDRs 09/23 September 23, 2019 6:42 AM - StreetInsider Gilead Sciences (GILD) Appears More Optimistic About Descovy During NDR - RBC September 19, 2019 6:42 AM - StreetInsider Popular stocks with increasing unusual volume: VALE SQ ROKU M T GILD September 12, 2019 4:07 AM - StreetInsider Nektar Therapeutics (NKTR) Strength Said Tied to Market Chatter September 11, 2019 11:06 AM - StreetInsider Companies with NDRs 09/11 September 11, 2019 6:41 AM - StreetInsider Gilead Sciences and the Elton John AIDS Foundation Launch RADIAN Initiative to Address HIV in Eastern Europe and Central Asia (EECA) September 9, 2019 7:30 AM - BizWire Press Release Biocartis NV: Biocartis announces H1 2019 results September 5, 2019 1:01 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Aug 28 Filed by: WOLD OLSEN PER August 29, 2019 4:42 PM - SEC Filing Form 8-K GILEAD SCIENCES INC For: Aug 23 August 27, 2019 4:28 PM - SEC Filing Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10 August 26, 2019 4:34 PM - BizWire RBC Capital Positive that Gilead Sciences (GILD) Didn't Acquire Otezla August 26, 2019 7:46 AM - StreetInsider Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration August 23, 2019 4:01 PM - BizWire Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration August 23, 2019 4:01 PM - StreetInsider Gilead Sciences (GILD) PT Lowered to $85 at Raymond James August 23, 2019 7:39 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Aug 19 Filed by: Pletcher Brett A August 20, 2019 3:13 PM - SEC Filing UPDATE: Gilead Sciences (GILD), Galapagos NV (GLPG) Report EMA Validates Marketing Application for Filgotinib for Treatment of Rheumatoid Arthritis August 15, 2019 4:01 PM - StreetInsider EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS August 15, 2019 4:01 PM - StreetInsider European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis August 15, 2019 4:01 PM - BizWire Gilead Sciences (GILD) Underperforms Despite A Steady Stream Of Good News - Oppenheimer August 15, 2019 7:03 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Aug 10 Filed by: Pletcher Brett A August 13, 2019 6:48 PM - SEC Filing Gilead Sciences (GILD) Announces China National Medical Products Administration Approves Biktarvy for Treatment of HIV-1 Infection August 9, 2019 8:32 AM - StreetInsider China National Medical Products Administration Approves Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection August 9, 2019 8:30 AM - BizWire Agenus (AGEN) Reports FDA Acceptance of IND Filing for AGEN2373 Triggers $7.5M Milestone Payment from Gilead Sciences Inc. (GILD) August 8, 2019 7:42 AM - StreetInsider Gilead Sciences (GILD) Statement on FDA Advisory Committee's Recommendation on Descovy for PrEP August 8, 2019 6:16 AM - StreetInsider Gilead Sciences Statement on U.S. Food and Drug Administration Advisory Committee’s Recommendation on Descovy for PrEP™ August 7, 2019 8:44 PM - BizWire Medicare to cover expensive cancer cell therapies August 7, 2019 5:37 PM - StreetInsider Gilead (GILD) Wins FDA Panel Backing for HIV Preventative Drug, Panel Voted 16 to 2 in Favor of Descovy - Bloomberg August 7, 2019 3:47 PM - StreetInsider Form 10-Q GILEAD SCIENCES INC For: Jun 30 August 6, 2019 4:27 PM - SEC Filing Popular stocks with increasing unusual volume: DIS V GILD FDX TEVA CHK August 6, 2019 11:19 AM - StreetInsider Ontario Provides Access to Biktarvy® for the Treatment of HIV August 6, 2019 8:00 AM - BizWire FDA Posts Briefing Document on Gilead Sciences's (GILD) Descovy Ahead of Meeting August 5, 2019 8:44 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $80 at Morgan Stanley August 1, 2019 8:44 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $82 at BMO Capital July 31, 2019 7:35 AM - StreetInsider Gilead Sciences (GILD) Reports a Low Quality Beat/Raise, PT to $86 at Raymond James July 31, 2019 6:18 AM - StreetInsider Gilead Sciences (GILD) Declares $0.63 Quarterly Dividend; 3.8% Yield July 30, 2019 5:21 PM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Jul 30 July 30, 2019 4:08 PM - SEC Filing Gilead Sciences (GILD) Tops Q2 EPS by 10c, Revises FY Guidance July 30, 2019 4:04 PM - StreetInsider Gilead Sciences Announces Third Quarter 2019 Dividend July 30, 2019 4:02 PM - BizWire Gilead Sciences Announces Second Quarter 2019 Financial Results July 30, 2019 4:01 PM - BizWire Gilead Sciences (GILD) option implied volatility bid up into EPS and outlook July 30, 2019 10:42 AM - StreetInsider Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments July 30, 2019 6:07 AM - StreetInsider Gilead Sciences (GILD) option implied volatility elevated into EPS and outlook July 29, 2019 10:54 AM - StreetInsider RBC Capital Upgrades Gilead Sciences (GILD) to Top Pick; 'Valuation Disconnect Too Big To Ignore' July 29, 2019 6:36 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jul 24 Filed by: Mercier Johanna July 26, 2019 5:41 PM - SEC Filing Gilead Sciences (GILD) traders bidding up IV into EPS and outlook July 26, 2019 10:49 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jul 23 Filed by: Pletcher Brett A July 25, 2019 6:38 PM - SEC Filing Full Article List